Next Financial Group’s Repros Therapeutics Inc. RPRX Stock Holding History

Next Financial Group’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-300	Closed	–	–	1982
2016 Q1	$0	Hold	300	–	–	﹤0.01%	2015
2015 Q4	$0	Sell	300 -650	-68%	-$2.09K	﹤0.01%	2099
2015 Q3	$7K	Hold	950	–	–	﹤0.01%	1353
2015 Q2	$6K	Buy	950 +150	+19%	+$1.17K	﹤0.01%	1463
2015 Q1	$6K	Sell	800 -500	-38%	-$4.47K	﹤0.01%	1466
2014 Q4	$13K	Sell	1,300 -2,550	-66%	-$21.7K	﹤0.01%	1163
2014 Q3	$38K	Buy	+3,850	New	+$57K	0.01%	1095

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

Next Financial Group's RPRX Position: Q2 2016 in Review

Next Financial Group sold out of Repros Therapeutics Inc. (RPRX) in Q2 2016, closing a stake of 300 shares.

Next Financial Group first reported a position in RPRX in Q3 2014 and held it in 7 quarters. The position peaked at $38K in Q3 2014. 43 funds tracked by Wall St. Rank hold RPRX as of Q2 2016.

Next Financial Group reported no remaining Repros Therapeutics Inc. position as of Q2 2016 after selling out during the quarter.
Next Financial Group sold 300 Repros Therapeutics Inc. shares in Q2 2016.
Next Financial Group first reported a position in Repros Therapeutics Inc. in Q3 2014 and held it in 7 quarters.
Next Financial Group's Repros Therapeutics Inc. position peaked at $38K in Q3 2014.
43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q2 2016.

Based on Next Financial Group's 13F filing for Q2 2016, filed 7 Jul 2016.